Publikation

Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study

Wissenschaftlicher Artikel/Review - 27.04.2014

Loriot Yohann, Ouatas Taoufik, Holtkamp Gertjan M, Baron Benoit, Heeringa Marten, Baskin-Bey Edwina, James Nicholas D, Omlin Aurelius, Molife Rhoda L, Van den Brande Jan, Jones Robert J, Fizazi Karim, de Bono Johann S